Athena UI V/ DE000A2QCX37 /
| NAV01/10/2024 | Chg.-0.1200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 117.9400EUR | -0.10% | paying dividend | Alternative Investments Worldwide | Universal-Investment ▶ |
GlobeNewswire
26/08
Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Fol...
GlobeNewswire
15/08
MAXGEVITY Mobility Supplements Win Pet Innovation Award for “Health Focused Dog Food Topper Product ...
GlobeNewswire
31/07
Costamare Inc. Reports Results for The Second Quarter and Six-Month Period Ended June 30, 2024
GlobeNewswire
24/07
Profire Energy Sets Second Quarter 2024 Earnings Call for Thursday, August 8, 2024, at 8:30 a.m. ET
GlobeNewswire
24/07
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows ...
GlobeNewswire
17/07
Enterprise Bank Appoints David Lynch as Managing Director and Chief Investment Officer, of Enterpris...
GlobeNewswire
08/07
Leading Shipowners Presented at the 4th Annual Capital Link Decarbonization in Shipping Forum
GlobeNewswire
02/07
Kratos Valkyrie Demonstrates Affordable Runway Flexibility with Recent Take-Off and Flight Operation...
GlobeNewswire
28/06
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphom...
GlobeNewswire
24/06
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at Americ...
GlobeNewswire
18/06
Parsons and the Niagara International Transportation Technology Coalition Celebrate Bi-National Proj...
